From ayahuasca in South America to the flower children of the 1960s, psychedelic drugs have long been used for both recreational and spiritual reasons. After decades of societal demonisation and criminalisation, psychedelics are entering uncharted territory - mainstream medicine. The research of the effects of psychedelics in treating psychiatric conditions such as anxiety, depression, PTSD, or addiction is experiencing a worldwide renaissance. What caused this sudden surge of interest in psychedelics in the scientific community? How does entering different states of consciousness manifest in the physiology of the brain and the user's mental health? Which substances are researched most frequently? What are the methodologies, risks and results that these studies yield? Can their responsible use contribute to self-development and lead to the decriminalisation of psychedelics for therapeutic or even recreational use? Explore the kaleidoscope of unforeseen potential that psychedelics present in a fascinating webinar with Dr Christopher Bernhard Timmerman Slater, a postdoc at Imperial College London, who specialises on the effects of DMT in the human brain and experience.